Table 2.

Baseline Medication Use^*

Characteristic	Placebo Group (n = 62)	SDD Group (n = 51)	p-value
Aspirin (any dose)	9 (15%)	9 (18%)	0.8
Non-steroidal anti-inflammatory agents	0	0
Steroids	0	0
Antibiotics	1 (2%)	0	>0.9
Statins	6 (10%)	8 (16%)	0.4
Non-statin lipid-lowering agent	0	0
Diuretics	8 (13%)	4 (8%)	0.5
Beta blockers	3 (5%)	3 (6%)	>0.9
Calcium channel blockers	4 (6%)	1 (2%)	0.4
Angiotensin-converting enzyme inhibitor/angiotensin receptor blockers	6 (10%)	6 (12%)	0.8
Nitrates	0	0
Thienopyridine adenosine diphosphate-receptor antagonists	0	0

^*Data are expressed as count (%)